PWAM
HRMY icon

Private Wealth Asset Management’s Harmony Biosciences HRMY Stock Holding History

Private Wealth Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Hold
300
– – ﹤0.01% 697
2026
Q1 		$8.4K Hold
300
– – ﹤0.01% 726
2025
Q4 		$11.2K Hold
300
– – ﹤0.01% 649
2025
Q3 		$8.27K Hold
300
– – ﹤0.01% 685
2025
Q2 		$9.48K Hold
300
– – ﹤0.01% 671
2025
Q1 		$9.96K Buy
+300
New +$10.8K ﹤0.01% 625

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Wealth Asset Management's HRMY Position: Q2 2026 in Review

Private Wealth Asset Management held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 300 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Private Wealth Asset Management first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.2K in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Private Wealth Asset Management held 300 shares of Harmony Biosciences worth $10.9K as of Q2 2026.
  • Private Wealth Asset Management left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #697 holding.
  • Private Wealth Asset Management first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Asset Management's Harmony Biosciences position peaked at $11.2K in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.